Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Wismilak Inti Makmur Tbk. (WIIM) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Wismilak Inti Makmur Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Wismilak Inti Makmur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Wismilak Inti Makmur Tbk. trades at Rp1,600 (market cap 3.4T, 1.57M 24h volume). The key difference: Wismilak Inti Makmur Tbk. is far larger — about 19.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Wismilak Inti Makmur Tbk. is more actively traded (1.57M versus 592.2K). Which is the better fit depends on your goals.

OBATWIIM
Market Cap
172.82B3.4T
Volume
592.2K1.57M
Lot
5.92K15.75K
Turnover
147.05M2.54B
Average Price
248.311,610.77
Value
147.05M2.54B
Indicative Equilibrium Price
2541,600
Indicative Equilibrium Volume
10187

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
WIIM
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Wismilak Inti Makmur Tbk.

PT Wismilak Inti Makmur Tbk (the Company) was established based on Notarial Deed No. 22 of Bagio Atmadja, S.H., dated December 14, 1994.

Read more on WIIM